STATE-OF-THE-ART OF SEROGROUP B STREPTOCOCCUS-INDUCED INFECTIONS AT THE PRESENT STAGE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper reviews the literature on the infections caused by Serogroup B streptococci (S. agalactiae). It considers the biological and environmental features of this microorganism and its pathogenic properties. A population group that is most susceptible to this microorganism and procedures for the prevention and treatment of infections caused by Streptococci of this group are described.

Full Text

Restricted Access

About the authors

O. A CHUCHUKINA

Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: olgnest1009@yandex.ru
Moscow

Igor A. BOCHKOV

Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: bochkovia@mail.ru
Moscow

References

  1. Рождественская А.С. Двухкомпонентная регуляторная система SAK188/SAK189 и ее влияние на свойства Streptococcus agalactiae. Автореф. дис.. канд. мед. наук. СПб, 2011.
  2. Gardam M.A., Low D.E., Saginur R. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch. Intern. Med. 1998; 158: 1704-1708.
  3. Тотолян А.А., Грабовская К.В. Стрептококки группы В в неонатальной патологии: механизм патогенного действия, диагностика и профилактика. Вестник АМН СССР 1990; 7: 36-40.
  4. Christensen K.K., Christensen P. Chlorhexidine for prevention of neonatal colonization with GBS. In: Christensen K.K., Christensen P., Ferrieri P. Neonatal group B streptococcal infection. Antibiotiсs and Chemotherapy. Basel: Karger, 1985; 348.
  5. Костюкова Н.Н., Абрикосова Н.Ю., Медведева С.Н. Стрептококк группы В при менингите и сепсисе новорожденных. ЖМЭИ1984; 9: 25-28.
  6. Зациорская С.А., Башмакова М.В. Калашникова Е.Н. Генерализованная инфекция плода и новорожденного, вызванная стрептококками группы В. Вопр. охраны материнства и детства 1987; 11: 60-62.
  7. Башмакова М.А., Кошелева Н.Г. Калашникова Е.П. Инфекция и бактериальная колонизация урогениталий у беременных, влияние на течение беременности, плода и новорожденного. Акуш. и гин. 1995; 1; 15-18.
  8. Бочков И.А., Семина Н.А., Шувчук М.С. Эпидемиологические и экологические особенности инфекций, вызываемых стрептококками сергруппы В у беременных женщин и новорожденных детей. Эпидемиол. и инфекц. бол. 2000; 2: 56-59.
  9. Apgar B. S., Greenberg G., Yen G. Prevention of group B streptococcal disease in the newborn. B. Am. Fam. Physician. 2005; 71 (5): 903-910.
  10. Luck S., Torny M., d’Agapeyeff K., Pitt A., Heath P., Breathnach A., Russell A.B. Estimated early-onset group B streptococcal neonatal disease. Lancet 2003; 361: 1953-1954.
  11. Nandyal R.R. Update on group B streptococcal infections: perinatal and neonatal periods. J. Perinat. Neonatal. Nurs. 2008; 22 (3): 230-237.
  12. Schuchat A., Zywicki S.S., Dinsmoor M. J. et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000; 105: 21-26.
  13. Law M.R., Palomaki G., Alfirevic Z. et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Societ. J. Med. Screen. 2005; 12: 60-68.
  14. Berner R. Infektionen durch Gruppe B streptokokken in der neonatalperiode. Monatsschr. Kinderheild. 2003; 151: 373-383.
  15. Lauer P., Rinaudo C.D., Soriani M. et al. Genome analysis reveals pili in group B streptococci. Science 2005; 309: 105.
  16. Rinaudo C.D., Rosini R., Galeotti C.L. et al. Specific invovement of Pulis Type 2a in biofilm formation in Group B streptococcus. PLoS ONE 2010; 5, Issue 2: e9216.
  17. Kimura K., Suzuki S., Wachino J. et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 2008; 52(6): 1326-1328.
  18. Брико М.И., Покровский В.И. Инфекции, вызываемые Streptococcus agalactiae. В кн.: В.И. Покровский, Н.И. Брико, Л.А. Ряпис. Стрептококки и стрептококкозы. М.: ГЭОТАР-Медиа, 2006. 546 с.
  19. Врожденные, перинатальные и неонатальные инфекции. Под ред. А. Гриноу, Дж. Осборна, Ш.Сазерленд. Пер. с англ. М.: Медицина, 2000; 288.
  20. Стрептококковая инфекция у детей. Учебно-методическое пособие. Под ред. проф. В.А. Воробьевой. Н. Новгород: Издательство НГМА, 2005. 80 с.
  21. Анкирская А.С. Роль стрептококков группы В в перинатальной патологии. Акуш. и гин. 1984; 9: 6-10.
  22. Red Book: Report of the Committee on Infectious Diseases. 27h ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006; 992.
  23. Baker C.J. Group B streptococcal infections. In: Baker C.J., Edwards M.S., Remington J.S., Klein J.O. Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders, 2001; 1091-1156.
  24. Baltimore R.S. Huie S.M., Meek J.I., Schuchat A. Early-onset neonatal sepsis in the era of group В streptococcal prevention. Pediatrics 2001; 108: 1094-1098.
  25. Boyer K.M. Neonatal group В streptococcal infections. Current Opinion Pediatrics 1995; 7: 13-18.
  26. Kenyon S.L., Taylor PJ., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes, ORACLE Collaborative Group. Lancet 2001; 357: 979-988.
  27. Николаева И.В. Стрептококковая инфекция группы В у новорожденных и грудных детей. Лечащий врач 2012; 1: 26.
  28. Van Dyke M.K., Phares C.R., Lynfield R. et al. Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 2009; 360: 2626-2636.
  29. Anthony B.F., Eisenstadt R., Carter J. et al. Genital and intestinal carriage of group B streptococci during pregnancy. J. Infect. Dis. 1981; 143: 761-766.
  30. Anthony B.F., Carter J., Eisentadt R., Rimer D.G. Carriage of group B streptococci during pregnancy: A puzzler. J. Infect. Dis. 1983; 147: 776.
  31. Маянский А.Н. Стрептококки: микробиология и патология. Вопросы диагностики в педиатрии 2010; 1: 9-19.
  32. Christian J. W., Charles S. L. Streptocоccus group B infections. eMedicine, Nov. 11, 2009. http://emedicine. medscape.com
  33. Eschenbach D.A. Specific bacterial infections: Group B streptococcus. GLOWM, 2009; 1756-2228.
  34. Simoes J.A., Alves V.M., Fracalanzza S.E. et al. Phenotypical characteristics of group B streptococcus in parturients. Braz. J. Infect. Dis. 2007; 11(2): 120-129.
  35. Barcaite E., Bartusevicius A., Tameliene R. et al. Prevalence of maternal group B streptococcal colonization in European countries. Acta Obstet. Gynecol. Scand. 2008; 87(3): 260-271.
  36. Kieran E., Matheson M., Mann A.G. et al. Group B streptococcus (GBS) colonization among expectant Irish mothers. Ir. Med. J. 1998; 91(1): 21-22.
  37. Lee B.K., Song Y.R., Kim M.Y. et al. Epidemiology of group B streptococcus in Korea pregnant women. J. Epidemiol. Infect. 2010; 138(2): 292-298.
  38. Ming-Jie Jang, Pi-Lin San, Kuo-Chang Wen et al. Prevalence of maternal group B streptococcus colonization and vertical transmission in low-risk women in a single institute. Journal of the Chinese Medical Association. 2012; 75: 25-28.
  39. Kubin V., Mrasticova H., Pavlova M. et al. Group B streptococcal infections. Zbl. Bact. Abt. Orig. 1987; A265(1-2): 210-217.
  40. Jackson L.A., Hilsdon R., Farlley M.M. et al. Risk factors for group B streptococcal disease in adults. Ann. Int. Med. 2004; 123(6): 415-420.
  41. Кудин А.П., Маржало Е.Ю. Клинические особенности и этиотропное лечение менингита, вызванного Streptococcus agalactiae, у детей. Мед. журн. 2012; 3: 135-138.
  42. Larsen B. Microbiology of the female genital tract. In: Pastorek J.G. (ed.): Obstetric and Gynecologic Infectious Disease. New York: Raven Press, 1994; 11-25.
  43. Ayaub E.M., Swingle H. Pathogenic mechanisms in neonatal GBS infection. In: Christensen K.K., Christensen P., Ferrieri P. Neonatal group B streptococcal infection. Antibiotics and Chemotherapy. Basel: Karger, 1985; 128-141.
  44. Hakansson S., Axemo P., Bremme K. et al. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonization. Acta Obstet. Gynecol. Scand. 2008; 87(3): 258-259.
  45. Prevention of perinatal group B streptococcal desiase-revised guidelines from CDC. MMWR Recom. Rep. 2010; 59(RR-10): 14.
  46. Centers for Disease Control and Prevent. MMWR 1996; 45: 1-24.
  47. Centers for Disease Control and prevention (CDC). Prevention of perinatal group В streptococcal disease: Revised Guidelines from CDC. MMWR 2002; 51: 10-22.
  48. Anon. Trends in prenatal group B streptococcal disease -United States, 2000-2006. MMWR 2009; 58(5): 109-112.
  49. Estrany X.C. Probable early onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Arch. Dis. Child. Fetal Neonatal. 2008; 93: 85-89.
  50. Johri А.К. Group B streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 2006; 4: 932-942.
  51. Heath P.T., Feldman R. G. Vaccination against group B streptococcus. Expert. Rev. Vaccines 2005; 4: 207-218.
  52. Jordan H.T., Farley M.M., Graig A. Revisiting the need for vaccine prevention of late onset neonatal group B streptococcal disease: a multistate, population based analysis. Pediatric. Infect. Dis. 2008; 27: 1057-1064.
  53. Wiswell T.E., Baumgart S., Gannon C.M., Spitzer A.R. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed. Pediatrics 1995; 95: 803-806.
  54. Turrentine M.A., Ramirez M.M. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstet. Gynecol. 2008; 112(2, part 1): 259-264.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies